Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 11 Show results per page	View Search Criteria \| Help With Results

Last Modified: 12/23/2008 First Published: 11/25/2005


1.		Phase I/II Study of Green Tea Extract (Polyphenon E) in Patients With Previously Untreated Stage 0-II Chronic Lymphocytic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				NCI				MAYO-MC0419 7303, NCI-7303, NCT00262743, CLLT-MAYO-MC0419


2.		Study of Polyphenon E in Addition to Erlotinib in Advanced Non Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				Other				H06-128 IND78,248, NCT00707252

Last Modified: 10/31/2008 First Published: 3/13/2006


3.		Phase II Randomized Study of Green Tea Extract (Polyphenon E®) for the Prevention of Cervical Cancer in Patients With Human Papillomavirus (HPV) and Low-Grade Cervical Intraepithelial Neoplasia (CIN 1)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Prevention				Active				18 and over				NCI				UARIZ-UAZ03-1-02 UARIZ-HSC-0540, UAZ03-1-02, NCT00303823

Last Modified: 6/10/2008 First Published: 8/6/2006


4.		Phase II Randomized Study of Green Tea or Polyphenon E in Preventing Lung Cancer in Former Smokers With Chronic Obstructive Pulmonary Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Prevention				Active				40 to 80				NCI				UARIZ-HSC-0353 U01-CA-101204, NCT00363805

Last Modified: 4/24/2008 First Published: 2/7/2008


5.		Phase II Randomized Study of Polyphenon E, A Defined Green Tea Catechin Extract, in Current or Former Smokers With Bronchial Dysplasia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Prevention				Active				45 to 74				NCI				BCCA-H07-02401 H07-02401, NCT00611650

Last Modified: 7/3/2008 First Published: 4/23/2008


6.		Phase II Randomized Study of Neoadjuvant Polyphenon® E (Defined Green Tea Catechin Extract) in Patients With Nonmetastatic Bladder Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Active				18 and over				NCI				WCCC-UWI06-8-01 UWI06-8-01, CO06810, H2007-0250, 07-1270-03, NCT00666562


7.		Study of Polyphenon E in Men With High-Grade Prostatic Intraepithelial Neoplasia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Prevention				Active				30 to 80				NCI, Other				MCC 15008 USF#105730, NCT00596011


8.		A Study of the Effect of Polyphenon E (Green Tea Extract) on Breast Cancer Progression

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Active				21 to 75				Other				H04-179 NCT00676793

Last Modified: 12/8/2008 First Published: 9/23/2005


9.		Phase IB Randomized Study of Green Tea Extract (Polyphenon E) in Preventing Esophageal Cancer in Patients With Barrett’s Esophagus

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Prevention				Active				18 and over				NCI				MDA-03101 NCT00233935, MDA03-101, MDA-2004-0907, CPMC-AAA0407

Last Modified: 6/13/2008 First Published: 4/2/2007


10.		Phase I Study of Defined Green Tea Catechin Extract in Patients With Prostate Cancer Scheduled to Undergo Prostatectomy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Biomarker/Laboratory analysis, Treatment				Active				18 and over				NCI				UARIZ-UAZ05-6-01 UAZ05-6-01, HSC# 06-0695-04, UARIZ-HSC-06-0695-04, NCT00459407

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute